News

Archive

March 17, 2014

Deciphera Pharmaceuticals Presents Preclinical Data on Rebastinib and DCC-3014 at AACR Tumor Microenvironment Conference

Archive

August 5, 2013

Deciphera announces appointment of John de Groot, MD to its Scientific Advisory Board

Archive

July 27, 2013

Deciphera announces appointment of John Condeelis to its Scientific Advisory Board

Archive

October 4, 2012

Deciphera Pharmaceuticals Announces Transition to an Oncology Drug Development Company

Archive

August 29, 2012

Deciphera Pharmaceuticals Announces Approval of rebastinib patent in Japan

Archive

June 11, 2012

Deciphera Pharmacueticals Announces Appointment of Kapil Bhalla, MD to its Scientific Advisory Board

Archive

April 26, 2012

Deciphera Pharmaceuticals Announces Appointment of Dr. Patrick O’Connor to its Scientific Advisory Board

Archive

February 1, 2012

Deciphera Pharmaceuticals Announces Collaboration Milestone with Eli Lilly and Company

Archive

July 18, 2011

Kansas Biosciences Authority Votes in Favor of a $1.6MM Product Development Grant to Deciphera

Archive

July 6, 2011

Deciphera Pharmaceuticals and the University of Kansas Cancer Center team up for clinical study of leukemia drug

Back to top